• LAST PRICE
    12.1400
  • TODAY'S CHANGE (%)
    Trending Down-0.2000 (-1.6207%)
  • Bid / Lots
    12.1400/ 7
  • Ask / Lots
    12.1500/ 6
  • Open / Previous Close
    12.2500 / 12.3400
  • Day Range
    Low 12.1250
    High 12.4700
  • 52 Week Range
    Low 7.2600
    High 17.4800
  • Volume
    433,853
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 12.34
TimeVolumeDVAX
09:32 ET2408112.47
09:33 ET396512.37
09:35 ET532112.39
09:37 ET403612.38
09:39 ET250012.41
09:42 ET670012.38
09:44 ET394312.39
09:46 ET224412.415
09:48 ET190012.425
09:50 ET584612.43
09:51 ET717212.45
09:53 ET202112.455
09:55 ET612112.45
09:57 ET202212.42
10:00 ET170012.44
10:02 ET532012.42
10:04 ET431212.405
10:06 ET259912.395
10:08 ET256412.365
10:09 ET681712.38
10:11 ET920312.355
10:13 ET407012.365
10:15 ET662612.39
10:18 ET220012.395
10:20 ET145012.39
10:22 ET636012.36
10:24 ET260012.36
10:26 ET2613012.3299
10:27 ET784912.32
10:29 ET260312.315
10:31 ET385412.34
10:33 ET217412.31
10:36 ET161212.315
10:38 ET1950712.3
10:40 ET140012.29
10:42 ET335612.3007
10:44 ET130012.28
10:45 ET30012.265
10:47 ET1341712.23
10:49 ET235312.2192
10:51 ET392812.19
10:54 ET633312.19
10:56 ET270012.195
10:58 ET140012.205
11:00 ET149412.19
11:02 ET220012.215
11:03 ET252812.215
11:05 ET155012.2
11:07 ET470212.1899
11:09 ET412312.15
11:12 ET398112.16
11:14 ET60012.19
11:16 ET282912.195
11:18 ET160812.2
11:20 ET271012.21
11:21 ET120012.2
11:23 ET139012.21
11:25 ET248212.24
11:27 ET204512.24
11:30 ET70012.215
11:32 ET350712.24
11:34 ET145112.24
11:36 ET287912.22
11:38 ET338512.22
11:39 ET62612.22
11:41 ET20012.215
11:43 ET211312.21
11:45 ET180012.215
11:48 ET267812.185
11:50 ET317012.195
11:52 ET450012.2029
11:54 ET449212.1795
11:56 ET160012.19
11:57 ET190012.195
11:59 ET1657012.17
12:01 ET162512.185
12:03 ET842612.14
12:06 ET514412.165
12:08 ET275212.155
12:10 ET203912.14
12:12 ET307612.13
12:14 ET130012.125
12:15 ET186112.14
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesDVAX
Dynavax Technologies Corp
1.6B
6.1x
---
United StatesIRWD
Ironwood Pharmaceuticals Inc
1.8B
12.3x
---
United StatesPIII
P3 Health Partners Inc
1.3B
-14.3x
---
United StatesRCUS
Arcus Biosciences Inc
1.9B
77.2x
---
United StatesQURE
Uniqure NV
1.3B
-10.2x
---
United StatesRGNX
Regenxbio Inc
978.9M
24.7x
---
As of 2022-11-28

Company Information

Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company that is focused on developing and commercializing vaccines. The Company's products include HEPLISAV-B and CpG 1018. The HEPLISAV-B is indicated for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose hepatitis B vaccine for adults. HEPLISAV-B is a sterile solution for injection presented in 0.5 mL single-dose prefilled syringes. The Company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. The Company is also engaged in developing CpG 1018 as a vaccine adjuvant through research collaborations and partnerships. HEPLISAV-B combines 1018, a toll-like receptor (TLR9) agonist adjuvant, and recombinant hepatitis B surface antigen (rHBsAg). It is primarily focused on adjuvanted vaccines for coronavirus disease (COVID-19), plague, Tdap, seasonal influenza, universal influenza, and shingles.

Contact Information

Headquarters
2100 Powell Street, Suite 720EMERYVILLE, CA, United States 94608
Phone
510-848-5100
Fax
510-848-1327

Executives

Independent Chairman of the Board
Scott Myers
President, Chief Operating Officer
David Novack
Chief Executive Officer, Director
Ryan Spencer
Chief Financial Officer, Senior Vice President
Kelly MacDonald
Chief Medical Officer, Senior Vice President - Clinical Development, Medical and Regulatory Affairs
Robert Janssen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.6B
Revenue (TTM)
$733.3M
Shares Outstanding
127.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.34
EPS
$2.01
Book Value
$1.81
P/E Ratio
6.1x
Price/Sales (TTM)
2.1
Price/Cash Flow (TTM)
4.8x
Operating Margin
41.06%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.